Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Julian C. Desmond"'
Autor:
James R. Shire, T. Roderick Hester, Jason Diamond, Steve Zvi Abrams, Davis B. Nguyen, Rod J. Rohrich, Zachary E. Gerut, Julian C. Desmond, Achih H. Chen, Laura Silvati-Fidell
Publikováno v:
Aesthetic Surgery Journal. 33:487-496
Background: Suction drains are commonly placed after rhytidectomy to avoid seroma formation that may result from dead spaces between skin layers. Fibrin sealants promote tissue adherence by crosslinking with extracellular matrix proteins, which may r
Autor:
Laura Silvati-Fidell, James R. Shire, Zachary E. Gerut, Achih H. Chen, Davis B. Nguyen, T. Roderick Hester, Julian C. Desmond, Jason Diamond, Steve Zvi Abrams
Publikováno v:
Aesthetic Surgery Journal. 33:323-333
Background: Suction drains are commonly placed after rhytidectomy surgery to avoid seroma formation that may result from dead spaces between skin layers. Fibrin sealants promote tissue adherence by cross-linking with extracellular matrix proteins, wh
Autor:
Takashi Kumagai, Sigal Gery, H. Phillip Koeffler, Norihiko Kawamata, Julian C. Desmond, Yasufumi Imai, Jee Hoon Song, Dorina Gui, Tadayuki Akagi, Jonathan W. Said
Publikováno v:
International Journal of Cancer. 124:827-833
Molecular-targeted therapy is a hopeful approach for pancreatic cancer. Silencing of tumor suppressor genes can occur by histone deacetylation and/or DNA methylation in the promoter. Here, we identified epigenetically silenced genes in pancreatic can
Autor:
Jinwei Hu, Bindu Konda, John M. Ong, Norihiko Kawamata, Dong Yin, Keith L. Black, H. Phillip Koeffler, Julian C. Desmond
Publikováno v:
Clinical Cancer Research. 13:1045-1052
Purpose: Histone acetylation is one of the main mechanisms involved in regulation of gene expression. During carcinogenesis, tumor-suppressor genes can be silenced by aberrant histone deacetylation. This epigenetic modification has become an importan
Autor:
Ronald Legaspi, Robert J. McKenna, Akio Mori, Naoki Komatsu, Alberto M. Marchevsky, Carl W. Miller, H. Phillip Koeffler, Julian C. Desmond, James O’Kelly
Publikováno v:
Cancer Investigation. 25:738-741
Cysteine-rich protein 61 (Cyr61) is a member of a family of growth factor-inducible, immediate-early genes. In this report, the authors measured the expression of Cyr61 mRNA in 94 human lung tumors and their normal matched lung samples. The Cyr61 mRN
Autor:
Julian C. Desmond, Takashi Kumagai, H. Phillip Koeffler, Martin Hewison, James O'Kelly, Susan V. Hughes, Lee-Yung Shih
Publikováno v:
Cancer Research. 65:2488-2497
Recently, we reported that a novel, noncalcemic vitamin D analogue (19-nor-1,25(OH)2D2; paricalcitol) had anticancer activity. In this study, we explored if paricalcitol enhanced anticancer effects of other clinically useful drugs in vitro against a
Autor:
Carl W. Miller, Jonathan Mordechai Frank, Wenwen Chien, Jonathan W. Said, H. Phillip Koeffler, Julian C. Desmond, Takashi Kumagai
Publikováno v:
Journal of Biological Chemistry. 279:53087-53096
Cyr61 (CCN1) is a member of the CCN protein family; these secreted proteins are involved in diverse biological processes such as cell adhesion, angiogenesis, apoptosis, and either growth arrest or growth stimulation depending on the cellular context.
Autor:
Andrew L. Lovering, Christopher M. Bunce, Stephen M. Cummings, Scott A. White, Jon P. Ride, Julian C. Desmond
Publikováno v:
Cancer Research. 64:1802-1810
It is becoming increasingly well established that nonsteroidal anti-inflammatory drugs (NSAID) protect against tumors of the gastrointestinal tract and that they may also protect against a variety of other tumors. These activities have been widely at
Autor:
Noriyuki Takai, Jonathan W. Said, Isao Miyakawa, Julian C. Desmond, H. Phillip Koeffler, Sadie Whittaker, Takashi Kumagai, Dorina Gui
Publikováno v:
Clinical Cancer Research. 10:1141-1149
Purpose: HDAC inhibitors (HDACIs) have been shown to inhibit cancer cell proliferation, stimulate apoptosis, and induce cell cycle arrest. Our purpose was to investigate the antiproliferative effects of the HDACIs [suberoyl anilide bishydroxamine, va
Autor:
S. L. Fenton, Christopher M. Bunce, K J W Mustard, J Pound, John Gordon, Mark T. Drayson, A Sarafeim, Julian C. Desmond, Q T Luong
Publikováno v:
Leukemia. 17:568-575
Current therapies for Burkitt's lymphoma (BL) utilise combined cytotoxic chemotherapy, but these treatments are not always available in areas where the disease is endemic and are also markedly less successful in AIDS-related BL. Therefore, additional